These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 7518517)

  • 1. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose methotrexate for gestational trophoblastic disease.
    Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
    Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
    Homesley HD; Blessing JA; Rettenmaier M; Capizzi RL; Major FJ; Twiggs LB
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):413-8. PubMed ID: 2457192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
    Soper JT; Clarke-Pearson D; Hammond CB
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):338-43. PubMed ID: 2831487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.
    Kwon JS; Elit L; Mazurka J; Moens F; Schmuck ML
    Gynecol Oncol; 2001 Aug; 82(2):367-70. PubMed ID: 11531296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-day methotrexate for women with metastatic gestational trophoblastic disease.
    Soper JT; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Gynecol Oncol; 1994 Jul; 54(1):76-9. PubMed ID: 8020843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-dose methrotrexate/folinic acid regimen in the chemotherapy of gestational trophoblastic disease.
    Khoo SK; Jones IS
    Med J Aust; 1980 Apr; 1(7):317-20. PubMed ID: 6248746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR; Brewer JI
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use.
    Kohorn EI
    J Reprod Med; 1991 Jan; 36(1):49-55. PubMed ID: 1848901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of low-risk metastatic gestational trophoblastic tumors.
    DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein MR
    J Reprod Med; 1991 Jan; 36(1):36-9. PubMed ID: 1848898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance?
    Kohorn EI
    Gynecol Oncol; 2002 Apr; 85(1):36-9. PubMed ID: 11925117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
    Goldstein DP; Goldstein PR; Bottomley P; Osathanondh R; Marean AR
    Obstet Gynecol; 1976 Sep; 48(3):321-3. PubMed ID: 181702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methotrexate in gynecologic oncology].
    Isonishi S; Terashima Y
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1896-900. PubMed ID: 8978793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study.
    Covens A; Filiaci VL; Burger RA; Osborne R; Chen MD;
    Cancer; 2006 Sep; 107(6):1280-6. PubMed ID: 16900525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk metastatic gestational trophoblastic disease.
    Gordon AN; Gershenson DM; Copeland LJ; Saul PB; Kavanagh JJ; Edwards CL
    Obstet Gynecol; 1985 Apr; 65(4):550-6. PubMed ID: 2580255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gestational trophoblastic tumors--a report of experiences].
    Ebeling K; Schönborn I; Johannsmeyer D
    Zentralbl Gynakol; 1995; 117(5):237-42. PubMed ID: 7540787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
    Abrão RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
    Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk metastatic gestational trophoblastic tumors. Current management.
    Lurain JR
    J Reprod Med; 1994 Mar; 39(3):217-22. PubMed ID: 7518518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
    van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
    J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia.
    Lurain JR
    Am J Obstet Gynecol; 2011 Jan; 204(1):11-8. PubMed ID: 20739008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.